Baylor College of Medicine; Gastroenterology

Houston, Texas 77030

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Transitional Cell, Crohn Disease

Studies at this site

• A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection — Stopped early
• A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed